With its broad base of expertise, the mission of the Georgia Center for Diabetes Translation Research (GCDTR) is to facilitate and grow Type 2 translation research in diabetes within the state of Georgia. Type 2 translation is defined as research focused on translating approaches that have clearly demonstrated efficacy into real world health care settings, and communities, at risk with an emphasis on reach, sustainability, and widespread implementation.
Emory University, in partnership with Georgia Tech and Morehouse School of Medicine, has received funding from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to establish the Georgia Center for Diabetes Translation Research (GCDTR). Dr. K. M. Venkat Narayan, Director of the Emory Global Diabetes Research Center at Emory University, along with Co-Directors Mohammad K. Ali and Guillermo Umpierrez, will lead the center.
This research studied the largest clinical lifestyle change program in the United States, the Veteran’s Health Administration’s MOVE! program.
Elizabeth K. Ely, Stephanie M. Gruss, Elizabeth T. Luman, Edward W. Gregg, Mohammed K. Ali, Kunthea Nhim, Deborah B. Rolka, and Ann L. Albright
This paper assesses participant-level results from the first 4 years of implementation of the National Diabetes Prevention Program (National DPP), a national effort to prevent type 2 diabetes in those at risk through structured lifestyle change programs.
Faculty researchers from Emory University, Morehouse School of Medicine, Georgia Tech, Georgia State University and the Atlanta Veterans’ Affairs System are eligible to propose studies that align with GCDTR's Cores. Click on the link above for more information!
Deadline: September 5, 2017
For all application and scientific questions, please contact: M’balu Oke, email@example.com